SECTION 8-ACCEPTED
accepted
on 29 May 2024
Last Applicant/ Owned by
2317 COTNER AVE
LOS ANGELES
CA
900641803
Serial Number
86681088 filed on 01st Jul 2015
Registration Number
5461609 registered on 08th May 2018
Correspondent Address
LOS ANGELES, CA 90064-1803
United States
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
ALEXSO INC.
Pharmaceutical preparations for the treatment and temporary relief of pain, excluding prescription pharmaceutical preparations delivered through inhalation technology for the treatment or symptomatic treatment of immunological diseases, pulmonary diseases, diseases in the field of neurology and psychiatry; medical plasters; medical and surgical dressings
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and temporary relief of pain, excluding prescription pharmaceutical preparations delivered through inhalation technology for the treatment or symptomatic treatment of immunological diseases, pulmonary diseases, diseases in the field of neurology and psychiatry; medical plasters; medical and surgical dressings
First Use Date in General
30th Mar 2010
First Use Date in Commerce
30th Mar 2010
Mark Details
Serial Number
No 86681088
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 5461609
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Sep 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 29th May 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 29th May 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 29th May 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 28th May 2024 | PETITION TO DIRECTOR GRANTED |
| 21st May 2024 | TEAS RESPONSE TO PETITION INQUIRY LETTER |
| 21st May 2024 | PETITION INQUIRY LETTER ISSUED |
| 15th May 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 07th May 2024 | ASSIGNED TO PETITION STAFF |
| 24th Apr 2024 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |